Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Insights
Menu

Application US20190247324
Gw Pharmaceuticals, Plc

One Or A Combination Of Phyto-cannabinoids In The Treatment Of Epilepsy

This invention relates to the use of one or more cannabinoids in the treatment of epilepsy and more particularly to the use of one or a combination of cannabinoids in the treatment of generalized or partial seizure. In one embodiment it relates to the use of the cannabinoid THCV, as a pure or isolated compound, or as a plant extract in which significant amounts of any THC naturally present has been selectively removed. In another embodiment the phytocannabinoid is CBD.

Much More than Average Length Specification


1 Independent Claims

  • Claim CLM-01-10. 1.-10. (canceled)
  • Claim CLM-00011. 11. A method of treating complex partial seizure that remains localized comprising administering cannabidiol (CBD) to a patient, wherein the CBD is present in an amount which provides a daily dose of at least 400 mg, and the CBD is present as a pure or isolated cannabinoid.


View Abstract and Specification Size

PDF with Images and Document Face >

Full Text Publication >



Patent Matrix® Search


USPTO Patent Document Number